Park Place Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Park Place Capital's MDGL Position: Q2 2026 in Review
Park Place Capital sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2026, closing a stake of 4 shares — an estimated $2.09K sold.
Park Place Capital first reported a position in MDGL in Q2 2024 and held it in 8 quarters. The position peaked at $2.33K in Q4 2025. 417 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.
- Park Place Capital reported no remaining Madrigal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Park Place Capital sold 4 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $2.09K.
- Park Place Capital first reported a position in Madrigal Pharmaceuticals in Q2 2024 and held it in 8 quarters.
- Park Place Capital's Madrigal Pharmaceuticals position peaked at $2.33K in Q4 2025.
- 417 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.
Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.